Nine Months Felt Too Long After William Harris’s PSA Kept Rising: An American Patient’s Prostate Cancer Treatment in Tijuana

Publish date: Medically reviewed by: Dr. Orhan Sencan on Sep 10, 2026 Author: Aamina Bibi

American Patient’s Prostate Cancer Treatment in Tijuana 

Patient Profile

Name: William Harris

Age: 61

Condition: Localized/intermediate-risk prostate cancer

Treatment: Robotic-assisted prostatectomy or specialized radiation therapy

Destination: Tijuana, Mexico

Journey at a Glance

Main problems: Escalating PSA levels, urinary frequency, pelvic pain, and sleep disruption.

Previous care: Multiple insurance appeals denied for specific modalities, quoted 9-month wait times for specialists, and prohibitive USD 60,000+ out-of-pocket estimates domestically.

Travel driver: Seeking rapid access to treatment modalities insurance denied, avoiding total depletion of retirement savings, and finding proximity for family support.

Treatment explored: Robotic-assisted prostatectomy (da Vinci) or brachytherapy with experienced oncological teams.

Personal goal: Halt disease progression, preserve baseline bodily functions, and regain agency over a stalled medical process.

You started sleeping in the guest room so your frequent trips to the bathroom wouldn't wake your wife.

You stopped drinking water after six in the evening.

You learned to ignore the dull, persistent ache in your lower pelvis while driving to work.

You memorized the hold music for your health insurance provider's prior authorization department.

You sat quietly through consultations where specialists looked more at their screens than at your face.

You nodded when they told you the schedule was just a bit backed up this year.

You pretended not to notice when your wife checked your bank balance late at night.

"We can always borrow against the house if we have to."

"I just want you to be healthy, whatever it takes."

"Did the scheduler call back with a real date yet?"

Your world has quietly become smaller.

You have come to understand that the hardest part of a cancer diagnosis isn't the physical pain or even the financial terror, but the relentless, hollow reality of waiting.

William Harris does not actually exist.

He is not a real patient whose medical records have been published for promotional purposes.

He is a fictional composite built from the actual situations, clinical roadblocks, and midnight anxieties that men across the American Southwest face every year.

William is sixty-one years old and lives in a suburb of Phoenix, Arizona.

He spent thirty-five years working as a civil engineer, calculating structural loads and managing municipal water projects.

He takes pride in maintaining his own vehicles and keeping his yard immaculate.

He approaches problems systematically, gathering data before making a move.

The escalation caught him entirely off guard.

He blamed the sudden urinary hesitation on getting older.

He assumed the lower back pain was from a weekend spent replacing patio pavers.

He scheduled a routine physical only because his wife, Sarah, left the clinic's phone number on his keyboard.

The elevated PSA level led to a biopsy.

The biopsy required a three-week wait for results.

He spent that time organizing his tools in the garage.

When the urologist finally called him into the office, the conversation was brief.

The standard recommendation for his specific presentation often involves surgical removal of the prostate gland or targeted radiation therapy, depending on the tumor's grade and staging .

The doctor looked at his chart and delivered the verdict:

"Intermediate-risk localized prostate cancer."

William asked the only logical question:

"When?"

The American medical system answers that question in its own time.

Across the United States, patients seeking urological oncologists often encounter substantial delays, with some regions reporting wait times of several months for initial surgical consultations alone .

Insurance network complexities and prior authorization requirements frequently add further administrative barriers between a diagnosis and the operating room.

But William doesn't experience these structural bottlenecks as a national statistic.

He experiences them sitting at his kitchen table, staring at an explanation of benefits that denies coverage for the specific robotic procedure his surgeon recommended.

"They want you to try conventional radiation first," the clinic's billing coordinator explains over the phone.

He experiences them when he calls an out-of-network surgical center and is quoted USD 72,000 for the procedure.

"We do offer a twelve-month financing plan," the financial counselor suggests.

He experiences them when his own in-network urologist finally admits the truth:

"I can't get you on the surgical schedule until October."

William has already tried to be patient.

He is not an impulsive shopper looking for a medical bargain.

He filed the first insurance appeal meticulously, attaching his doctor's clinical notes.

He filed the second appeal with a letter from his primary care physician.

He contacted three other local urology practices to check their wait lists.

He spent a weekend reading through the inclusion criteria for clinical trials.

He pulled his retirement account statements and calculated the penalty for early withdrawal.

"I just need to play by their rules," he told himself.

"The system is slow, but it works eventually."

But as the dull pelvic ache sharpens into a daily reality, his internal calculus shifts.

The fundamental question transforms from whether he can tolerate the waiting to:

"How much of my life am I prepared to organise around it?"

The nearer alternative is technically possible.

William could accept the nine-month delay and hope the tumor remains contained within the prostatic capsule.

He could drain his 401(k) to bypass the insurance denial and pay for the robotic surgery out of pocket.

He could take a second mortgage on the house he spent twenty years paying off.

But draining a retirement fund isn't just about moving money from one account to another.

It is the erasure of his future security to purchase his present survival.

Sarah sits across from him with a calculator and a notepad.

"We have the savings to just pay them," she says quietly.

"But that money is for our retirement, not for buying access to care we already pay premiums for."

William isn't searching for Tijuana yet.

He sits in the dark living room at 2:00 a.m. with his laptop illuminating his face.

His search history documents a quiet descent into desperation.

Prostate cancer progression speed if untreated for 9 months
Da Vinci robotic prostatectomy out of pocket cost Arizona
Medical bankruptcy laws and primary residence
Robotic prostate surgery abroad for US citizens
Prostate cancer treatment Tijuana Mexico

When the search engine returns dozens of clinics operating just south of the California border, his initial reaction is deeply skeptical.

He spent his career managing risk and rejecting substandard materials.

"I'm not going to Mexico just because a website says it's cheaper," he mutters to the empty room.

His instinct is entirely correct.

Price should never be the mechanism that answers a complex oncological question.

Why does this specific city keep appearing in his research?

Tijuana's proximity to major US healthcare hubs like San Diego and Los Angeles has driven decades of cross-border medical integration.

Current advisory guidelines note that many international medical hubs maintain rigorous accreditation standards, though outcomes rely heavily on the specific facility chosen .

Many surgeons operating in these border zones complete fellowships in the United States or hold certifications from international urological boards.

William realizes his framework is flawed:

Countries do not perform surgery.

Surgeons perform surgery.

Clinical teams manage recovery.

Hospitals adhere to protocols.

This means there is something concrete he can actually verify, rather than relying on geopolitical assumptions.

His first question was: "How much?"

The indicative cost for robotic-assisted prostatectomy in Tijuana commonly varies between USD 15,000 and USD 25,000.

This range is influenced by the choice of facility, the specific robotic system utilized, pathology fees, and the duration of inpatient recovery required .

It represents a fraction of the USD 60,000 to USD 120,000 he was quoted in Arizona.

He hears his late father's voice in his head:

"You always get exactly what you pay for, son."

But William knows from his municipal contracts that sometimes you are just paying for administrative bloat.

"What exactly am I getting?"

Does this price include the initial surgical consultation and pre-operative lab work?

Is the anesthesiologist's fee billed separately?

Does it cover the cost of the surgical robot consumables and specialized trocars?

Are the pathology reports for the removed tissue included?

How many nights in the hospital ward are factored into this estimate?

What happens to the price if I need an extra day of monitoring?

Are post-operative medications like antibiotics and pain relievers provided?

Does the clinic handle the hotel accommodations for my wife?

Is ground transportation from the San Diego airport coordinated by their team?

What if I experience a complication that requires readmission?

Do they provide translated medical records for my oncologist back home?

Who do I call if my catheter causes pain three days after I fly back?

He understands quickly that the advertised number is only the very beginning of the conversation.

What does the procedure actually involve?

During a robotic-assisted radical prostatectomy, a surgeon sits at a console controlling precision instruments inserted through several small incisions in the patient's abdomen.

The goal is to extract the entire prostate gland and seminal vesicles while attempting to spare the delicate nerve bundles responsible for erectile function and urinary control .

It is a major operation requiring general anesthesia, meticulous tissue handling, and weeks of careful healing.

Which brings William to a logistical reality he hadn't fully considered.

"How do I manage the trip home?"

The brochures rarely feature pictures of Foley catheters.

Medical tourism marketing tends to gloss over the unglamorous realities of post-operative recovery.

Clinical guidance indicates that patients typically require a urinary catheter for one to two weeks following a prostatectomy, during which time travel can be highly uncomfortable and carries increased risk of venous thromboembolism .

The variation in how clinics handle this recovery period is exactly the lesson William needs to learn.

This physical constraint must dictate his travel plan before he commits to a date, not as an afterthought.

"Wait. Does that mean I'm flying with a drainage bag strapped to my leg?"

Possibly, depending on how long you choose to stay in a local recovery hotel before flying.

Will the airline require a medical clearance letter to let me board?

How do I empty the bag safely in a cramped airplane lavatory?

What happens if the catheter gets blocked while I'm at 30,000 feet?

Should we just drive the six hours back to Arizona instead of flying?

If we drive, how often do we need to stop to prevent blood clots in my legs?

Who will change the surgical dressings while we stay in the hotel?

Is the hotel bathroom equipped with grab bars and a walk-in shower?

How do I communicate with hotel staff if I need extra towels and don't speak fluent Spanish?

Will my domestic urologist agree to remove the catheter once I am back home?

He writes these questions down in a spiral notebook.

This isn't medical tourism in the usual sense.

Sarah isn't just coming along for the ride.

William realizes that his wife will bear the brunt of the operational logistics.

She is the one who will carry the luggage because he is under strict lifting restrictions.

She is the one who will listen to the discharge instructions and remember the medication schedule.

She is the one who will have to notice if his temperature spikes at two in the morning.

Official consular guidance recommends that US citizens travelling abroad for healthcare secure specialized medical complication insurance, as standard domestic health plans rarely cover international emergencies .

Sarah is not a passive companion on this trip.

She is the critical fail-safe in his care system.

Then comes the uncomfortable conversation about risk.

Prostatectomy carries inherent risks regardless of geography, including long-term urinary incontinence, erectile dysfunction, and pelvic infection.

William learns to distrust any representative who glosses over these realities.

He crosses off clinics that use specific phrases in their marketing:

Completely safe. No risk. Guaranteed success.

True informed consent requires a provider who will look a patient in the eye and explain exactly how a procedure can fail.

William's questions become sharper.

He stops asking if a clinic is good and starts asking how they operate.

How many robotic prostatectomies has this specific surgeon performed this year?
What is the surgeon's personal rate of nerve-sparing success?
Is the surgical robot a modern da Vinci Xi system or an older generation model?
What happens if the pathology report shows positive surgical margins?
Does the clinic have an on-site intensive care unit if something goes wrong during anesthesia?
Are the surgical instruments sterilized on-site or contracted to a third party?
Who is legally responsible if a surgical error occurs?
Will the surgeon conduct the follow-up via telemedicine, or a nurse?
Do you have a formalized agreement with any local US urologists for complication management?
What would you see on my MRI scans that would make you tell me not to proceed?

He does not just want a surgeon willing to perform the operation.

He wants a surgeon who possesses the clinical integrity to refuse him if the risk is too high.

Has he truly exhausted his domestic options?

Before making a final decision, William must look backward one last time.

Patients in the US have specific grievance rights and can sometimes force an insurance network to cover an out-of-network provider if timely access is unavailable locally .

He needs answers from his current clinic:

Can you put me on a cancellation list for an earlier date?
Is there a financial hardship program at this hospital I haven't applied for?
Will the oncology board review my denial appeal again?
If I choose active surveillance for six months, what specific markers will we monitor?
If I leave the country for surgery, will you agree to manage my long-term PSA monitoring when I return?

The choice requires a fair baseline.

Tijuana should be compared with William's real domestic alternatives, not with a worst-case assumption about his current providers.

The night before the decision.

The same kitchen table is now covered in documents.

His printed MRI report.

The final denial letter from his insurance company.

The detailed itinerary from the clinic in Tijuana.

A printed list of questions the Mexican surgeon answered directly during their video consultation.

"I think I know what we need to do," he says to Sarah.

"Then let's get the passports out of the safe," she replies.

The extensive research didn't make him more afraid of the procedure.

It simply made him more capable of deciding.

What William actually wants isn't robotic surgery.

His brother calls and asks if he is excited about getting the tumor out.

William says yes, because that is the expected answer.

But the real answer is far more mundane.

He wants to sleep through the night without waking up in pain.

He wants to stop calculating the distance to the nearest restroom whenever he leaves the house.

He wants to watch his grandson graduate high school in five years without worrying about metastasis.

Not a medical tourism package.

Not a cheap invoice.

Not a trip to Mexico.

Not a surgical robot.

Control.

And underneath that:

Agency.

Tijuana might be the answer, but it might not be.

William could decide the logistics of traveling with a catheter are too daunting.

He could secure a loan and pay the exorbitant US hospital fee for peace of mind.

His domestic urologist might suddenly find a cancellation slot next week.

He might choose localized radiation therapy in Arizona instead of surgery.

He might decide the risk of surgical complications abroad outweighs his fear of the waiting list.

Any of those can be an informed, valid decision.

The objective of this exploration is not to persuade a man to leave his home country for medical care.

The goal is to ensure that frustration and fear do not make the decision for him.

Maybe you know exactly how William feels.

Maybe you are staring at an insurance denial letter right now.

Maybe you are tired of pretending the pelvic pain isn't getting worse.

Maybe you are dreading another phone call with a billing department.

Maybe you are looking at your retirement statements and feeling sick to your stomach.

Maybe your spouse is pushing you to just do something, anything, to fix this.

You do not need to decide today.

What is the actual clinical risk of waiting six more months?

Is my current doctor legally required to help me coordinate follow-up care if I go elsewhere?

How much support will my partner realistically need if we travel?

What specific robotic surgical platform am I being quoted for?

How will I handle the physical discomfort of the flight home?

Am I willing to manage my own medical records transfer?

What is the exact protocol if I suffer a post-operative infection?

You aren't just comparing prices anymore.

You are comparing paths forward.

Hope isn't the promise that cancer is easy to beat.

Hope is not a guarantee that a robotic surgery will leave you with perfect continence.

Hope is not a marketing brochure promising a pain-free recovery.

Hope is not pretending that traveling for major surgery is a vacation.

Hope is having enough transparent, verifiable information to make a choice that actually feels like yours.

It is the ability to ask difficult questions.

It is the capacity to reject unacceptable answers.

It is the strength to protect your family's financial future.

It is the determination to step out of the waiting room.

It is the moment the internal dialogue shifts.

From "I suppose I'll just have to keep waiting."

To:

"What other informed options do I have?"

PlacidWay — Your Way to Hope.

We help patients explore their international medical options, compare facility credentials, and prepare the rigorous questions necessary for informed consent. We do not provide clinical advice, and we do not perform surgery.

For someone facing systemic delays or prohibitive costs for prostate cancer treatment, crossing the border isn't a guaranteed promise, but it is one route worth understanding fully before making a decision.

Your Way to Hope.

Medical disclaimer

This article is for educational and informational purposes only and does not recommend that any individual undertake travel for medical procedures. Prostate cancer treatment carries inherent risks, and individual suitability requires comprehensive professional assessment. The reader must consult their own primary care physician, oncologist, or qualified clinical adviser before making any medical decisions. Always verify the current regulatory status, accreditation, and credentials of any international provider independently, and ensure you obtain appropriate medical complication insurance prior to travel.

Nine Months Felt Too Long After William Harris’s PSA Kept Rising: An American Patient’s Prostate Cancer Treatment in Tijuana

About Article

  • Translations: EN ES
  • Treatment: Cancer Treatment
  • Country: Mexico
  • Overview William Harris faces rising PSA levels, urinary symptoms and a long wait for specialist treatment in the United States. Tijuana offers proximity, but the right pathway depends on accurate staging and risk classification. Those results should guide comparison of prostatectomy, radiation or appropriate surveillance, alongside cancer control, urinary and sexual side effects, clinician experience, pathology review and coordinated follow-up at home.

Trusted Medical Tourism Platform Since 2007

60+
Countries
2k+
Clinics
19.5k+
Reviews
2.5k+
Qualified Doctors
1.1M+
Patients Served Since 2007